戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 17作成日:2026年10月23日

5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine → 5-Fluoro-N-(2-fluoro-4-(morpholinomethyl)phenyl)-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine

https://huagongshe.com/ja/reaction/17

反応式

関与物質

役割名称HCID仕込み量
反応物5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amineHCID 16665498—
反応物4-(4-Bromo-3-fluorobenzyl)morpholineHCID 53417818—
試薬Sodium 2-methylbutan-2-olateHCID 2733478—
触媒TriphenylphosphineHCID 11776—
触媒PalladiumHCID 23938—
溶媒TolueneHCID 1140—
生成物5-Fluoro-N-(2-fluoro-4-(morpholinomethyl)phenyl)-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amineHCID 4978201373%

反応条件

温度110 °C

反応手順

The aim of the reaction is test/optimization: 5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine (100 mg, 0.36 mmol), 4-(4-bromo-3-fluorobenzyl)morpholine (109 mg, 0.40 mmol), Palladium, 10% On Charcoal (115 mg, 0.11 mmol), Triphenylphosphine (0.038 mL, 0.16 mmol) and Sodium tert-pentoxide (79 mg, 0.72 mmol) were dissolved in toluene (1.5 mL) and heated to 110 °C under argon. The reaction was monitorred by HPLC. After 16 h 73 % conversion was achieved. The reaction was stopped and the mixture was discarded.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-572b233d6c664fada44bd8d3bb48fc2f
出典メモ750 AstraZeneca ELN dataset